Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS)

Related articles

1. Real‑World Safety Signals of Tirzepatide Versus GLP‑1RAs: A Machine Learning Analysis of FDA FAERS Data

   This article has 8 authors:

   1. Sherry Yun Wang
   2. Zhouzhou Chu
   3. Ang Li
   4. Daniel Umoru
   5. Ariel Tran
   6. Bowei Tian
   7. Peihao Dou
   8. Tannaz Moin

2. PCSK9 Inhibitors Do Not Increase Cognitive Risk

   This article has 7 authors:

   1. Dongsheng Ni
   2. Zeying Feng
   3. Dehuan Liang
   4. Zhaolai Qi
   5. Yao Lu
   6. Liyong Zhu
   7. Guoping Li

3. A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.

   This article has 1 author:

   1. Kaossara Osseni